Analysis of websites containing packageinserts.bms.com backlinks

These websites are/were linking to packageinserts.bms.com.

Websites found: 15
Number of websited displayed: 15

List of results:

Cómo ELIQUIS® (apixaban) puede ayudar | Información de seguridad

http://site-overview.com/stats/eliquisespanol.com

Website Address renewal date: 17/7/18
Domain Address Reg. date: 14/7/22
Website address in use until: 18/7/22

OPDIVO® (nivolumab) | Patient Gateway

http://site-overview.com/stats/opdivo.com

OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.

Website Address renewal date: 16/11/1
Domain Address Reg. date: 12/11/6
Website address in use until: 17/11/6

Resources

http://site-overview.com/stats/bmscustomerconnect.com

Website Address renewal date: 16/4/24
Domain Address Reg. date: 14/4/29
Website address in use until: 17/4/29

OPDIVO® (nivolumab) | HCP | Metastatic Urothelial Carcinoma (mUC)

http://site-overview.com/stats/opdivoinformationhcp.com

OPDIVO® (nivolumab), for treatment of patients with previously treated locally advanced or metastatic urothelial carcinoma. See Indication and Important Safety Information.

Website Address renewal date: 17/10/6
Domain Address Reg. date: 16/10/10
Website address in use until: 18/10/10

SPRYCEL (dasatinib) for Healthcare Professionals

http://site-overview.com/stats/sprycel-hcp.com

Find the latest safety and efficacy data for SPRYCEL® (dasatinib) for adult and pediatric patients. Visit SPRYCEL-hcp.com for more information.

Website Address renewal date: 17/3/27
Domain Address Reg. date: 10/3/31
Website address in use until: 18/3/31

YERVOY®(ipilimumab) | Consumer | Gateway

http://site-overview.com/stats/yervoy.com

YERVOY® (ipilimumab), prescription medication. See Indication, Important Safety Information, and Boxed Warning.

Website Address renewal date: 17/5/4
Domain Address Reg. date: 09/5/8
Website address in use until: 18/5/8

Chemo Facts – Dr. Rath Health Foundation

http://site-overview.com/stats/chemo-facts.com

Dr Rath Foundation

Google Analytics ID: 58365126-23
Website Address renewal date: 17/10/27
Domain Address Reg. date: 07/11/7
Website address in use until: 18/11/7

ORENCIA® (abatacept) | Official Patient Website

http://site-overview.com/stats/orencia.com

The ORENCIA® (abatacept) site provides Important Safety Information and Full Prescribing Information. Visit orencia.bmscustomerconnect.com to learn more

Website Address renewal date: 17/1/20
Domain Address Reg. date: 01/1/24
Website address in use until: 18/1/24

SPRYCEL® (dasatinib) | SPRYCEL.com

http://site-overview.com/stats/sprycel.com

Learn about SPRYCEL® (dasatinib)

Website Address renewal date: 16/6/27
Domain Address Reg. date: 02/7/1
Website address in use until: 17/7/1

COUMADIN® | What is COUMADIN®

http://site-overview.com/stats/coumadin.com

Learn about COUMADIN®, a prescription medicine. Read Important Safety Information and access Prescribing Information including BOXED WARNING and Medication Guide.

Website Address renewal date: 17/1/15
Domain Address Reg. date: 97/1/18
Website address in use until: 18/1/19

OPDIVO® (nivolumab) | Information for Healthcare Professionals

http://site-overview.com/stats/opdivohcp.com

Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.

Website Address renewal date: 17/2/27
Domain Address Reg. date: 14/3/3
Website address in use until: 18/3/3

Official Healthcare Professional Site | ORENCIA® (abatacept)

http://site-overview.com/stats/orenciahcp.com

Our site offers info for healthcare providers treating patients with moderate to severe rheumatoid arthritis. See Important Safety Info and Prescribing Info.

Website Address renewal date: 17/2/26
Domain Address Reg. date: 15/3/2
Website address in use until: 18/3/2

EMPLICITI™ (elotuzumab)

http://site-overview.com/stats/empliciti.com

Learn about EMPLICITI™ (elotuzumab) treatment which includes information about ongoing support and resources.

Website Address renewal date: 17/4/18
Domain Address Reg. date: 09/4/22
Website address in use until: 18/4/22

HIV-1 Treatment l Atripla® (efavirenz/emtricitabine/tenofovir disoproxil fumarate)

http://site-overview.com/stats/atripla.com

Learn about ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) an HIV-1 treatment. See Safety Info including Boxed WARNING and Full Prescribing Info.

Website Address renewal date: 17/3/2
Domain Address Reg. date: 05/3/29
Website address in use until: 18/3/29

OPDIVO® (nivolumab) | Patients | Advanced Urothelial Carcinoma (Bladder Cancer)

http://site-overview.com/stats/opdivoinformation.com

Information for consumers about OPDIVO® (nivolumab), a prescription medicine for previously treated bladder cancer (urothelial carcinoma) that has spread or grown. See Indication and Important Safety Information.

Website Address renewal date: 17/10/6
Domain Address Reg. date: 16/10/10
Website address in use until: 18/10/10